![Daniel Deardorf](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Daniel Deardorf is currently the Chief Executive Officer & Director at Glycologix, Inc. He previously worked as the Senior Vice President-Commercial at Flexion Therapeutics, Inc.
Aktive Positionen von Daniel Deardorf
Unternehmen | Position | Beginn |
---|---|---|
Glycologix, Inc.
![]() Glycologix, Inc. BiotechnologyHealth Technology Glycologix, Inc. is an American biotechnology company that develops delivered biopolymers for the protection and repair of soft tissues. Glycologix was founded by Thomas Jozefiak and George Adaniya, and the CEO is Dan Deardorf. | Vorstandsvorsitzender | 01.01.2021 |
Ehemalige bekannte Positionen von Daniel Deardorf
Unternehmen | Position | Ende |
---|---|---|
FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Flexion Therapeutics, Inc.
![]() Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Glycologix, Inc.
![]() Glycologix, Inc. BiotechnologyHealth Technology Glycologix, Inc. is an American biotechnology company that develops delivered biopolymers for the protection and repair of soft tissues. Glycologix was founded by Thomas Jozefiak and George Adaniya, and the CEO is Dan Deardorf. | Health Technology |